Jalila El Bakkouri

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Mark S. Anderson, P. Gregersen, R. Nussbaum, 2021, Science Immunology.

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

P. Gregersen, J. Casanova, L. Rowen, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children

V. Tillmann, P. Soler-Palacín, T. Ozcelik, 2024, The Journal of experimental medicine.

Human T-bet governs the generation of a distinct subset of CD11chighCD21low B cells

J. Casanova, A. Bousfiha, S. Tangye, 2022, Science Immunology.

Hematological and biochemical abnormalities associated with severe forms of COVID-19: A retrospective single-center study from Morocco

L. Belyamani, Amal Haoudar, C. El kettani, 2021, PloS one.